Immatics IMTX
NASDAQ IMTX
$9.56 +0.10 (+1.06%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immatics (IMTX) Net Income (2019 - 2026)

Immatics (IMTX) posted Net Income of -$41.6 million for Q4 2025, up 86.88% sequentially from -$316.8 million in Q3 2025, and down 195.42% YoY from $43.6 million in Q4 2024.

Analysis

Immatics (IMTX) Net Income (2019 - 2026) Analysis & Trends

Immatics has reported Net Income for 7 years, with the latest figure at -$41.6 million in Q4 2025.

  • Quarterly Net Income fell 195.42% year-over-year to -$41.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$230.4 million (down 1630.47% YoY) and the FY2025 annual result came in at -$221.9 million, down 1447.51% from the prior year.
  • Net Income grew to -$41.6 million in Q4 2025 per IMTX's latest filing, from -$316.8 million in the prior quarter.
  • Over five years, Net Income peaked at $169.9 million in Q2 2025 and troughed at -$316.8 million in Q3 2025.
  • A 5-year average of -$13.9 million and a median of -$20.2 million in 2021 frame the typical range for Net Income.
  • The sharpest annual moves came in 2023 and 2025: Net Income soared 663.89% in 2023, then sank 1622.77% in 2025.
  • Over 5 years, Net Income stood at -$19.2 million in 2021, then advanced by 29.7% to -$13.5 million in 2022, then surged by 663.89% to $76.1 million in 2023, then sank by 42.79% to $43.6 million in 2024, then slumped by 195.42% to -$41.6 million in 2025.
  • According to Business Quant data, Net Income over the past three periods registered -$41.6 million, -$316.8 million, and $169.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 601.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -644.37 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 81.49 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -13.27 Mn
10 Immatics 1.17 Bn 711.21 Mn - 207.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 207.04 Mn
Mar 31, 2026 -67.69 Mn
Dec 31, 2025 415.79 Mn
Sep 30, 2025 -316.76 Mn
Jun 30, 2025 169.86 Mn
Mar 31, 2025 -41.92 Mn
Dec 31, 2024 43.55 Mn
Sep 30, 2024 -50.27 Mn
Jun 30, 2024 24.20 Mn
Mar 31, 2024 -2.43 Mn
Dec 31, 2023 178.06 Mn
Sep 30, 2023 -28.84 Mn
Jun 30, 2023 -26.80 Mn
Mar 31, 2023 -21.20 Mn
Dec 31, 2022 -23.51 Mn
Sep 30, 2022 -21.11 Mn
Jun 30, 2022 -14.92 Mn
Mar 31, 2022 96.14 Mn
Dec 31, 2021 194.34 Mn
Sep 30, 2021 -148.47 Mn